{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:23:51Z","timestamp":1794536631584,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EvansMDS Foundation"},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL080472"],"award-info":[{"award-number":["R01HL080472"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL082945"],"award-info":[{"award-number":["R01HL082945"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-023-00326-7","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T08:15:11Z","timestamp":1693901711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-0986","authenticated-orcid":false,"given":"Philipp J.","family":"Rauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3895-8188","authenticated-orcid":false,"given":"Jayakrishnan","family":"Gopakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-3140","authenticated-orcid":false,"given":"Alexander J.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nachun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-9614","authenticated-orcid":false,"given":"Herra","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"McConkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9979-2682","authenticated-orcid":false,"given":"Tetsushi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-8059","authenticated-orcid":false,"given":"Marc","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Rentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Vivanco Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7836-4379","authenticated-orcid":false,"given":"Noah F.","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin F.","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zumana","family":"Khair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Gopakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0270-3688","authenticated-orcid":false,"given":"Kameron B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-0321","authenticated-orcid":false,"given":"Eti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Fefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Vromman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Shvartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Sukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Bendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-5067","authenticated-orcid":false,"given":"Michael","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-502X","authenticated-orcid":false,"given":"Peter","family":"Libby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5451","authenticated-orcid":false,"given":"Benjamin L.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-0477","authenticated-orcid":false,"given":"Siddhartha","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"326_CR1","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).","journal-title":"Science"},{"key":"326_CR2","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"326_CR3","doi-asserted-by":"publisher","first-page":"e005375","DOI":"10.1161\/CIRCOUTCOMES.118.005375","volume":"12","author":"AN Nowbar","year":"2019","unstructured":"Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P. & Al-Lamee, R. Mortality from ischemic heart disease. Circ Cardiovasc. Qual. Outcomes 12, e005375 (2019).","journal-title":"Circ Cardiovasc. Qual. Outcomes"},{"key":"326_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg3354","volume":"14","author":"ZD Smith","year":"2013","unstructured":"Smith, Z. D. & Meissner, A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204\u2013220 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"326_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","volume":"22","author":"RL Bowman","year":"2018","unstructured":"Bowman, R. L., Busque, L. & Levine, R. L. Clonal hematopoiesis and evolution to hematopoietic malignancies. Cell Stem Cell 22, 157\u2013170 (2018).","journal-title":"Cell Stem Cell"},{"key":"326_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129\u20131133 (2010).","journal-title":"Nature"},{"key":"326_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300\u20131303 (2011).","journal-title":"Science"},{"key":"326_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","volume":"20","author":"K Moran-Crusio","year":"2011","unstructured":"Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11\u201324 (2011).","journal-title":"Cancer Cell"},{"key":"326_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.stem.2014.06.018","volume":"15","author":"GA Challen","year":"2014","unstructured":"Challen, G. A. et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 15, 350\u2013364 (2014).","journal-title":"Cell Stem Cell"},{"key":"326_CR10","doi-asserted-by":"crossref","unstructured":"Cimmino, L. et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170, 1079\u20131095.e20 (2017).","DOI":"10.1016\/j.cell.2017.07.032"},{"key":"326_CR11","doi-asserted-by":"crossref","unstructured":"Pan, W. et al. The DNA methylcytosine dioxygenase Tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression. Immunity 47, 284\u2013297.e5 (2017).","DOI":"10.1016\/j.immuni.2017.07.020"},{"key":"326_CR12","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","volume":"118","author":"Z Li","year":"2011","unstructured":"Li, Z. et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509\u20134518 (2011).","journal-title":"Blood"},{"key":"326_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal, S. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377, 111\u2013121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"326_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","volume":"141","author":"AG Bick","year":"2020","unstructured":"Bick, A. G. et al. Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation 141, 124\u2013131 (2020).","journal-title":"Circulation"},{"key":"326_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano, S. et al. CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ. Res. 123, 335\u2013341 (2018).","journal-title":"Circ. Res."},{"key":"326_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","volume":"4","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer, L. et al. Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol. 4, 25\u201333 (2019).","journal-title":"JAMA Cardiol"},{"key":"326_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster, J. J. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842\u2013847 (2017).","journal-title":"Science"},{"key":"326_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/nm.3258","volume":"19","author":"CS Robbins","year":"2013","unstructured":"Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166\u20131172 (2013).","journal-title":"Nat. Med."},{"key":"326_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41590-020-0768-4","volume":"21","author":"JW Williams","year":"2020","unstructured":"Williams, J. W. et al. Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression. Nat. Immunol. 21, 1194\u20131204 (2020).","journal-title":"Nat. Immunol."},{"key":"326_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","volume":"117","author":"FK Swirski","year":"2007","unstructured":"Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195\u2013205 (2007).","journal-title":"J. Clin. Invest."},{"key":"326_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson, E. C. et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol. 7, 521\u2013528 (2022).","journal-title":"JAMA Cardiol."},{"key":"326_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","volume":"592","author":"TP Fidler","year":"2021","unstructured":"Fidler, T. P. et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature 592, 296\u2013301 (2021).","journal-title":"Nature"},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","volume":"38","author":"P Libby","year":"2013","unstructured":"Libby, P., Lichtman, A. H. & Hansson, G. K. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38, 1092\u20131104 (2013).","journal-title":"Immunity"},{"key":"326_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"326_CR25","doi-asserted-by":"crossref","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"326_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","volume":"127","author":"A Zernecke","year":"2020","unstructured":"Zernecke, A. et al. Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas. Circ. Res. 127, 402\u2013426 (2020).","journal-title":"Circ. Res."},{"key":"326_CR27","doi-asserted-by":"crossref","unstructured":"Cochain, C. et al. Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ. Res. 122, 1661\u20131674 (2018).","DOI":"10.1161\/CIRCRESAHA.117.312509"},{"key":"326_CR28","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.117.312513","volume":"122","author":"H Winkels","year":"2018","unstructured":"Winkels, H. et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ. Res. 122, 1675\u20131688 (2018).","journal-title":"Circ. Res."},{"key":"326_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185\u2013194 (2007).","journal-title":"J. Clin. Invest."},{"key":"326_CR30","doi-asserted-by":"crossref","unstructured":"Keren, L. et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 174, 1373\u20131387.e19 (2018).","DOI":"10.1016\/j.cell.2018.08.039"},{"key":"326_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","volume":"40","author":"S Epelman","year":"2014","unstructured":"Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91\u2013104 (2014).","journal-title":"Immunity"},{"key":"326_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"326_CR33","doi-asserted-by":"publisher","first-page":"e20211872","DOI":"10.1084\/jem.20211872","volume":"218","author":"PG Kim","year":"2021","unstructured":"Kim, P. G. et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J. Exp. Med. 218, e20211872 (2021).","journal-title":"J. Exp. Med."},{"key":"326_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41591-018-0064-0","volume":"24","author":"M Nahrendorf","year":"2018","unstructured":"Nahrendorf, M. Myeloid cell contributions to cardiovascular health and disease. Nat. Med. 24, 711\u2013720 (2018).","journal-title":"Nat. Med."},{"key":"326_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"326_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1101\/gad.2036011","volume":"25","author":"H Wu","year":"2011","unstructured":"Wu, H. et al. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 25, 679\u2013684 (2011).","journal-title":"Genes Dev."},{"key":"326_CR37","doi-asserted-by":"crossref","unstructured":"Cobo, I. et al. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. Immunity 55, 1386\u20131401.e10 (2022).","DOI":"10.1016\/j.immuni.2022.06.022"},{"key":"326_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain, D. A. et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25, 442\u2013454 (2014).","journal-title":"Cancer Cell"},{"key":"326_CR39","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2013-02-483487","volume":"122","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J. et al. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 122, 4086\u20134089 (2013).","journal-title":"Blood"},{"key":"326_CR40","doi-asserted-by":"crossref","unstructured":"Huang, Y. H. et al. Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor. Cancer Discov. 12, 220\u2013235 (2022).","DOI":"10.1158\/2159-8290.CD-21-0560"},{"key":"326_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrc3895","volume":"15","author":"L Yang","year":"2015","unstructured":"Yang, L., Rau, R. & Goodell, M. A. DNMT3A in haematological malignancies. Nat. Rev. Cancer 15, 152\u2013165 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"326_CR42","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41591-021-01411-9","volume":"27","author":"R Saiki","year":"2021","unstructured":"Saiki, R. et al. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis. Nat. Med. 27, 1239\u20131249 (2021).","journal-title":"Nat. Med."},{"key":"326_CR43","doi-asserted-by":"publisher","first-page":"e13366","DOI":"10.1111\/acel.13366","volume":"20","author":"D Nachun","year":"2021","unstructured":"Nachun, D. et al. Clonal hematopoiesis associated with epigenetic aging and clinical outcomes. Aging Cell 20, e13366 (2021).","journal-title":"Aging Cell"},{"key":"326_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s44161-022-00171-0","volume":"1","author":"M Mokry","year":"2022","unstructured":"Mokry, M. et al. Transcriptomic-based clustering of human atherosclerotic plaques identifies subgroups with different underlying biology and clinical presentation. Nat. Cardiovasc. Res. 1, 1140\u20131155 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"326_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35089-5","volume":"13","author":"Z Andrysik","year":"2022","unstructured":"Andrysik, Z., Sullivan, K. D., Kieft, J. S. & Espinosa, J. M. PPM1D suppresses p53-dependent transactivation and cell death by inhibiting the integrated stress response. Nat. Commun. 13, 7400 (2022).","journal-title":"Nat. Commun."},{"key":"326_CR46","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/dvdy.21176","volume":"236","author":"S Nguyen","year":"2007","unstructured":"Nguyen, S., Meletis, K., Fu, D., Jhaveri, S. & Jaenisch, R. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev. Dyn. 236, 1663\u20131676 (2007).","journal-title":"Dev. Dyn."},{"key":"326_CR47","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"326_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"326_CR49","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"326_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature24489","volume":"551","author":"AL Haber","year":"2017","unstructured":"Haber, A. L. et al. A single-cell survey of the small intestinal epithelium. Nature 551, 333\u2013339 (2017).","journal-title":"Nature"}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00326-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:04:30Z","timestamp":1694617470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00326-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":50,"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1038\/s44161-023-00326-7","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B. is presently a consultant for the company IonPath Inc., which manufactured the MIBI-TOF instrument used in this paper. A.E.L. is a member of TenSixteen Bio, outside of the submitted work. E.M. previously consulted for IonPath Inc. M.A. is a board member and shareholder in IonPath, which develops and manufactures the commercial MIBI-TOF platform. P.L. is an unpaid consultant to, or involved in, clinical trials for Amgen, AstraZeneca, Baim Institute, Beren Therapeutics, Esperion Therapeutics, Genentech, Kancera, Kowa Pharmaceuticals, Medimmune, Merck, Moderna, Novo Nordisk, Novartis, Pfizer and Sanofi-Regeneron. P.L. is a member of the scientific advisory board for Amgen, Caristo Diagnostics, Cartesian Therapeutics, CSL Behring, DalCor Pharmaceuticals, Dewpoint Therapeutics, Eulicid Bioimaging, Kancera, Kowa Pharmaceuticals, Olatec Therapeutics, Medimmune, Novartis, PlaqueTec, TenSixteen Bio, Soley Therapeutics and XBiotech, Inc. P.L.\u2019s laboratory has received research funding in the last 2\u2009years from Novartis, Novo Nordisk and Genentech. P.L. is on the Board of Directors of XBiotech, Inc. and has a financial interest in XBiotech, a company developing therapeutic human antibodies; in TenSixteen Bio, a company targeting somatic mosaicism and CHIP to discover and develop new therapeutics to treat age-related diseases; and in Soley Therapeutics, a biotechnology company that is combining artificial intelligence with molecular and cellular response detection for discovering and developing new drugs, currently focusing on cancer therapeutics. P.L.\u2019s interests were reviewed and are managed by Brigham and Women\u2019s Hospital and Mass General Brigham in accordance with their conflict-of-interest policies. B.L.E. has received consulting fees from GRAIL. He is a member of the scientific advisory board and shareholder for Neomorph Therapeutics, Skyhawk Therapeutics and Exo Therapeutics. B.L.E.\u2019s laboratory has received research funding in the last 2\u2009years from Novartis and Calico. S.J. is a scientific advisor to AstraZeneca, Novartis, Genentech, AVRO Bio and Foresite Labs, reports speaking fees from GSK, is an equity holder and on the scientific advisory board for Bitterroot Bio, and is an equity holder, co-founder and on the scientific advisory board of TenSixteen Bio. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}